Tibor M. Brunt

Instability of the ecstasy market and a new kid on the block: mephedrone

Tibor M. Brunt, Anneke Poortman, Raymond J.M. Niesink et al. · Journal of Psychopharmacology · 2010 · 217 citations

Differential Regulation of Interleukin-10 (IL-10) and IL-12 by Glucocorticoids In Vitro

Jeroen Visser, Anette H.H. van Boxel-Dezaire, Dion Methorst et al. · Blood · 1998 · 200 citations

Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project

Tibor M. Brunt, Constanze Nagy, Alexander Bücheli et al. · Drug Testing and Analysis · 2016 · 179 citations

Substance Use, Drug Policy, Drug Screening +22

Monitoring new psychoactive substances (NPS) in The Netherlands: Data from the drug market and the Poisons Information Centre

Laura Hondebrink, Johanna J. Nugteren–van Lonkhuyzen, Daan van der Gouwe et al. · Drug and Alcohol Dependence · 2014 · 117 citations

Substance Abuse, Psychoactive Drug, Substance Use +12

Cross‐sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study

Peggy van der Pol, Nienke Liebregts, Tibor M. Brunt et al. · Addiction · 2014 · 114 citations